Lupin Limited (BOM:500257)
2,301.70
-42.75 (-1.82%)
At close: Mar 9, 2026
Lupin Employees
Lupin had 24,006 employees as of March 31, 2025. The number of employees increased by 2,138 or 9.78% compared to the previous year.
Employees
24,006
Change (1Y)
2,138
Growth (1Y)
9.78%
Revenue / Employee
10.89M INR
Profits / Employee
1.93M INR
Market Cap
1,051.98B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,811 |
| Torrent Pharmaceuticals | 17,059 |
| Abbott India | 3,659 |
| GlaxoSmithKline Pharmaceuticals | 3,113 |
| J. B. Chemicals & Pharmaceuticals | 5,304 |
| AstraZeneca Pharma India | 600 |
| Granules India | 4,066 |
| Jubilant Pharmova | 5,547 |
Lupin News
- 3 days ago - Lupin Ranks No. 1 Globally in Pharma; Tops All Sectors in India in S&P ESG Assessment 2025 - Business Upturn
- 10 days ago - Lupin Goa facility clears US FDA inspection with VAI classification - Business Upturn
- 13 days ago - Lupin receives USFDA approval for Brivaracetam Oral Solution, launches in US market - Business Upturn
- 21 days ago - Lupin signs licensing and supply agreement with Spektus Pharma to commercialise DeslaFlex in Canada - Business Upturn
- 24 days ago - Lupin Ltd (BOM:500257) Q3 2026 Earnings Call Highlights: Record Growth and Strategic Milestones - GuruFocus
- 24 days ago - Q3 2026 Lupin Ltd Earnings Call Transcript - GuruFocus
- 4 weeks ago - Lupin launches Topiramate Extended-Release Capsules in the US after FDA approval - Business Upturn
- 5 weeks ago - Lupin collaborates with TB Alliance to advance new treatment for Tuberculosis and other mycobacterial diseases - Business Upturn